Third, our cellular results also showed that METTL3 could regulate the expression of HHLA2 via m6A modification of HHLA2 mRNA, leading to the mRNA stability, thus epigenetically increasing the expression of HHLA2 in ccRCC progression. This evidence concerns the gene HHLA2 and nonpapillary renal cell carcinoma.